>What level of agreement is there with the problem statements?
>What data/analysis is there to support/refute the problem statements?
>What level of detail are organisations prepared to share with regards the assays, data, established correlations and sequence/structure?
>How much data do we need to make a difference and how are we going to test this?
>Who will ‘own’ and manage data?
>What internal related efforts are ongoing?
GSK questions on data sharing:
What would the data repository be?
Where would it be? An independent third party?
How secure would it be and what kind of maintenance would it require?
Would we require a neutral location for any wet work?
If the data was held securely by a third party, how would we then use it? Would that require another third party to build the algorithm or perhaps a PhD student?
Or would we generate descriptors on the whole data set and then send these back out?